연구성과로 돌아가기

2025 연구성과별 연구자 정보 (362 / 1187)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Efficacy and safety of safinamide in Parkinson's disease patients with motor fluctuations without levodopa dosage escalation over 18 weeks: KEEP study Park, Mee Young Park, MY 8 Yeungnam Univ, Coll Med, Dept Neurol, Daegu, South Korea jsbaik@paik.ac.kr;
Efficacy and safety of safinamide in Parkinson's disease patients with motor fluctuations without levodopa dosage escalation over 18 weeks: KEEP study Kwon, Do-Young Kwon, DY 9 Korea Univ, Ansan Hosp, Dept Neurol, Coll Med, Ansan, South Korea jsbaik@paik.ac.kr;
Efficacy and safety of safinamide in Parkinson's disease patients with motor fluctuations without levodopa dosage escalation over 18 weeks: KEEP study Il, Hyeo Ma Il, HM 10 Hallym Univ, Sacred Heart Hosp, Hallym Univ Sacred Heart Hosp, Dept Neurol, Anyang, South Korea jsbaik@paik.ac.kr;
Efficacy and safety of safinamide in Parkinson's disease patients with motor fluctuations without levodopa dosage escalation over 18 weeks: KEEP study Park, Jeong-Ho Park, JH 11 Soonchunhyang Univ, Bucheon Hosp, Coll Med, Dept Neurosurg, Bucheon Si, Gyeonggi Do, South Korea jsbaik@paik.ac.kr;
Efficacy and safety of safinamide in Parkinson's disease patients with motor fluctuations without levodopa dosage escalation over 18 weeks: KEEP study Koh, Seong-Beom Koh, SB 12 Korea Univ, Guro Hosp, Dept Neurol, Guro Hosp, Seoul, South Korea jsbaik@paik.ac.kr;
Efficacy and safety of safinamide in Parkinson's disease patients with motor fluctuations without levodopa dosage escalation over 18 weeks: KEEP study Choi, Seong-Min Choi, SM 13 Chonnam Natl Univ, Chonnam Natl Univ Hosp, Med Sch, Dept Neurol, Gwangju, South Korea jsbaik@paik.ac.kr;
Efficacy and safety of safinamide in Parkinson's disease patients with motor fluctuations without levodopa dosage escalation over 18 weeks: KEEP study Park, Jinse Park, J 14 Inje Univ, Haeundae Paik Hosp, Dept Neurol, Busan, South Korea jsbaik@paik.ac.kr;
Efficacy and safety of safinamide in Parkinson's disease patients with motor fluctuations without levodopa dosage escalation over 18 weeks: KEEP study Lee, Phil Hyu Lee, PH 15 Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea KOC-2534-2024 Lee, Jun-Hyuk jsbaik@paik.ac.kr;
Efficacy and safety of safinamide in Parkinson's disease patients with motor fluctuations without levodopa dosage escalation over 18 weeks: KEEP study Ahn, Tae-Beom Ahn, TB 16 Kyung Hee Univ, Kyung Hee Univ Hosp, Kyung Hee Univ Hosp, Dept Neurol, Seoul, South Korea AAG-1309-2021 Ahn, Tae-Beom jsbaik@paik.ac.kr;
Efficacy and safety of safinamide in Parkinson's disease patients with motor fluctuations without levodopa dosage escalation over 18 weeks: KEEP study Kim, Sang Jin Kim, SJ 17 Inje Univ, Coll Med, Busan Paik Hosp, Dept Neurol, Busan 614110, South Korea IQS-7291-2023 Kim, Yong Joon jsbaik@paik.ac.kr;
Efficacy and safety of safinamide in Parkinson's disease patients with motor fluctuations without levodopa dosage escalation over 18 weeks: KEEP study Lyoo, Chul Hyoung Lyoo, CH 18 Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Neurol, Seoul, South Korea jsbaik@paik.ac.kr;
Efficacy and safety of safinamide in Parkinson's disease patients with motor fluctuations without levodopa dosage escalation over 18 weeks: KEEP study Lee, Ho-Won Lee, HW 19 Kyungpook Natl Univ, Sch Med, Dept Neurol, Daegu 700422, South Korea AAE-7526-2022 Lee, Ho Won jsbaik@paik.ac.kr;
Efficacy and safety of safinamide in Parkinson's disease patients with motor fluctuations without levodopa dosage escalation over 18 weeks: KEEP study Kim, Jieun Kim, J 20 Eisai Korea Inc, Med Dept, Seoul, South Korea jsbaik@paik.ac.kr;
Efficacy and safety of safinamide in Parkinson's disease patients with motor fluctuations without levodopa dosage escalation over 18 weeks: KEEP study Lee, Yoona Lee, Y 21 Eisai Korea Inc, Med Dept, Seoul, South Korea jsbaik@paik.ac.kr;
Efficacy and safety of safinamide in Parkinson's disease patients with motor fluctuations without levodopa dosage escalation over 18 weeks: KEEP study Baik, Jong Sam Baik, JS 22 교신저자 Inje Univ, Sanggye Paik Hosp, Dept Pathol, Seoul, South Korea jsbaik@paik.ac.kr;
페이지 이동: